Hypotension After Anesthetic Induction with Remimazolam in Elderly
NCT ID: NCT05538741
Last Updated: 2024-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
62 participants
INTERVENTIONAL
2023-07-14
2024-06-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bolus Versus Continuous Remimazolam for Anesthetic Induction
NCT05536323
Remifentanil and Midazolam on Propofol for Loss of Consciousness in Elderly Patients
NCT02818387
Median Effective Dose of Remimazolam for Sedation in Elderly Patients
NCT05468996
Effects of Remimazolam on the Intraoperative Hemodynamics in Bypass Surgery
NCT05557253
Remimazolam and Propofol Anesthesia in Elderly Patients
NCT05201300
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bolus
Remimazolam bolus injection for 20 seconds
Bolus of remimazolam
0.19-0.25 mg/kg for 60-80 years old 0.14-0.19 mg/kg for \>80 years old
Continuous
Remimazolam continuous infusion
Continuous infusion of remimazolam
12 mg/kg/hr until loss of consciousness
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bolus of remimazolam
0.19-0.25 mg/kg for 60-80 years old 0.14-0.19 mg/kg for \>80 years old
Continuous infusion of remimazolam
12 mg/kg/hr until loss of consciousness
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* scheduled for elective surgery under general anesthesia
* American Society of Anesthesiology Physical Status I-III
Exclusion Criteria
* Liver dysfunction
* Kidney dysfunction
* Uncontrolled hypertension
* Uncontrolled diabetes mellitus
* Allergic to benzodiazepines
* Heart failure
* Drug intoxication
* Alcoholics
* Cognitive dysfunction
* Unable to understand and consent voluntarily
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kangbuk Samsung Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eunah Cho, MD
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eunah Cho, PhD
Role: PRINCIPAL_INVESTIGATOR
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kangbuk Samsung Hospital
Seoul, Seoul, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RMZ_bolcon_old
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.